Max C. Lin (Menlo Park) joined KKR in 2005. He is Co-Head of the Health Care industry team within KKR’s Americas Private Equity platform and sits on the Health Care Strategic Growth Investment Committee. Mr. Lin currently serves on the board of directors of BrightSpring Health Services, Covenant Surgical Partners, Envision Healthcare, Global Medical Response, Heartland Dental, and PetVet Care Centers. He was also involved in the firm’s investments in Coherus BioSciences, HCA, PRA Health Sciences, Zimmer Biomet, Go Daddy, and The Nielsen Company. Prior to joining KKR, Mr. Lin was with Morgan Stanley where he was involved in a number of mergers, acquisitions, and financing transactions. He holds a B.S. and B.A.S., summa cum laude, from the University of Pennsylvania and an M.B.A. from Harvard Business School.